AUM
Not publicly reported
Estimated Dry Powder
Not publicly reported
Fund Size (Latest)
Thynk Capital Fund II
$10M
Estimated Cheque Size
$100K-$100K
Stages
- Seed
- Series A
- Series B
Fund Details
About
Thynk Capital is a US-based venture capital firm that focuses on investing in early-stage pharma and biotech companies. More specifically, the firm focuses on major diseases of aging including Alzheimer's, dementia, kidney disease, cancer, cardiovascular, diabetes, frailty, and rare disease.
Locations
No additional office locations.